Isomorphic Labs’ $5B Series C is the largest venture round in European history

Isomorphic Labs, the London AI drug discovery company spun out of DeepMind in 2021, raised $5B in a Series C announced on 17 November 2026, co-led by Greenoaks and Sequoia. The round is 52% larger than Europe’s previous record, Mistral AI’s $3.3B Series D in September 2026.

Isomorphic has raised $7.7B from outside investors in three rounds since March 2025, and two of them are among Europe’s ten largest. The company has no drug in human trials yet; it plans its first clinical trials for the end of 2026. It has not disclosed a valuation, and Bloomberg reported talks at about $50B.

Isomorphic Labs’ $5B Series C is the largest venture round ever raised by a European company

Europe’s 10 largest venture rounds · 8 of the 10 were raised in 2025 or 2026

  1. 1Isomorphic LabsLondon · Nov 2026$5B
  2. 2Mistral AIParis · Sep 2026$3.3B
  3. 3NorthvoltStockholm · Jun 2021$2.75B
  4. 4Isomorphic LabsLondon · May 2026$2.1B
  5. 5NscaleLondon · Mar 2026$2B
  6. 6RevolutLondon · Jul 2025$2B
  7. 7Mistral AIParis · Sep 2025$1.87B
  8. 8HelsingMunich · Jul 2026$1.8B
  9. 9StegraStockholm · Sep 2023$1.65B
  10. 10StegraStockholm · Jun 2026$1.54B
Source: Dealroom.co · verified venture rounds, companies headquartered in Europe

A record that stood for five years

Northvolt’s $2.75B round in June 2021 was the largest venture round raised by a European company until September 2026, when Mistral AI raised $3.3B. Isomorphic’s round two months later is $1.7B larger again. Northvolt filed for bankruptcy in March 2025.

Northvolt’s $2.75B held Europe’s record for five years; it has been beaten twice since September

Largest venture round raised by a European company each year · dark bars set a new record

$250MMarkit
’10
’11
’12
$550MRocket Internet
’13
’14
’15
$1.2BOneWeb
’16
’17
’18
$1.25BOneWeb
’19
’20
$2.75BNorthvolt
’21
’22
’23
’24
’25
$5BIsomorphic LabsMistral AI $3.3B, Sep 2026
2026
Source: Dealroom.co · verified venture rounds, companies headquartered in Europe

40% of European health funding

European health companies have raised $17.6B in venture funding in 2026. Isomorphic’s Series B and Series C, $7.1B together, are 40% of it, and 13% of the $56B raised by European AI companies.

Isomorphic Labs has raised 40% of all venture funding for European health companies this year

Venture funding in 2026, to 18 November · Isomorphic’s Series B and C, $7.1B, in blue

  1. European health companies$17.6B raised in 202640%Isomorphic
  2. European AI companies$56B raised in 202613%Isomorphic
  3. All European companies$89.7B raised in 20268%Isomorphic
Source: Dealroom.co · companies headquartered in Europe

Who invested

Alphabet has invested in every round, directly and through GV and CapitalG. Isomorphic does not publish its shareholdings; City AM reported in October 2026 that Alphabet was still the majority owner. Of the ten investors named in the Series C, the UK Sovereign AI Fund is the only one headquartered in Europe. MGX is based in Abu Dhabi and Temasek in Singapore.

Seven of the ten named investors in the Series C are American; one is European

Isomorphic Labs’ investors by round, coloured by where they are headquartered · stake sizes not disclosed

United StatesEuropeMiddle EastAsia-PacificRest of world
SpinoutNov 2021$600MMar 2025$2.1BMay 2026$5BNov 2026
AlphabetUnited StatesOwner
GV United States · Alphabet
CapitalGUnited States · Alphabet
Thrive Capital United StatesLeadLead
GreenoaksUnited StatesLead
SequoiaUnited StatesLead
Andreessen HorowitzUnited States
MGXUnited Arab Emirates
TemasekSingapore
UK Sovereign AI FundUnited Kingdom
Source: Dealroom.co · company releases

Where Europe’s largest rounds get their money

43 of Europe’s 50 largest venture rounds had at least one US investor. Splitting each round equally among its named investors, US investors supplied 48% of the money and European investors 29%. In rounds raised in 2025 and 2026 the US share was 53%.

US investors put up 48% of the money in Europe’s 50 largest venture rounds; European investors 29%

Share of round value by investor headquarters · each round split equally among its named investors

United StatesEuropeMiddle EastAsia-PacificRest of world
  1. Isomorphic Labs Series CNov 2026 · 10 named investors70%10%10%10%
  2. Europe’s 50 largest rounds50 rounds, 2016–202648%29%9%10%
  3. Raised 2025–2621 of the 5053%29%10%
  4. Raised 2022–2411 of the 5031%38%8%10%14%
  5. Raised 2016–2118 of the 5049%25%7%18%
Source: Dealroom.co · verified venture rounds, companies headquartered in Europe

What this means

8 of Europe’s ten largest venture rounds were raised in 2025 or 2026, and most of the money in Europe’s largest rounds comes from investors outside Europe. The largest of them went to a company that has not yet started a clinical trial.

Research notes: method and sources

Rounds: Dealroom venture rounds for companies headquartered in Europe (Dealroom’s Europe region, which includes Türkiye), excluding mature companies and companies outside tech. The rankings use verified rounds only. Two companies are left out because they count as European only through a later move of their headquarters to Dublin: PDD Holdings ($3B in April 2018, then based in Shanghai) and Jazz Pharmaceuticals (2004, then based in Palo Alto). 2026 figures run to 18 November.

Investor regions: each investor’s headquarters as recorded by Dealroom. Stakes are not disclosed, so each round’s value is split equally among its named investors. Isomorphic’s round amounts are checked against the company’s releases; the Series C also had new investors the company did not name.

  1. Isomorphic Labs: Series C announcement (17 Nov 2026)
  2. Isomorphic Labs: Series B announcement (12 May 2026)
  3. tech.eu: Isomorphic Labs nets $600M in first external funding round (31 Mar 2025)
  4. TechCrunch: Isomorphic Labs raises $5B (17 Nov 2026)
  5. Dealroom news: Bloomberg on talks at about $50B (Nov 2026)
  6. City AM: funding talks and Alphabet majority ownership (8 Oct 2026)